Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Free Cash Flow Generation Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥46.33 Million represents 1% of operating cash flow (CN¥58.18 Million). Read 002365 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Explore 002365 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Qianjiang Yongan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002365 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.12x | CN¥-12.33 Million | CN¥105.71 Million | CN¥118.04 Million | ▼ -128.4% |
| 2023 | 0.41x | CN¥100.46 Million | CN¥244.26 Million | CN¥120.74 Million | ▼ -33.1% |
| 2022 | 0.62x | CN¥238.21 Million | CN¥387.28 Million | CN¥149.07 Million | ▲ +61.6% |
| 2021 | 0.38x | CN¥38.76 Million | CN¥101.81 Million | CN¥63.05 Million | ▼ -23.1% |
| 2020 | 0.49x | CN¥102.25 Million | CN¥206.66 Million | CN¥104.41 Million | ▲ +12.7% |
| 2019 | 0.44x | CN¥105.15 Million | CN¥239.55 Million | CN¥134.39 Million | ▲ +209.6% |
| 2018 | 0.14x | CN¥44.53 Million | CN¥314.02 Million | CN¥269.50 Million | ▲ +130.4% |
| 2017 | -0.47x | CN¥-92.15 Million | CN¥197.32 Million | CN¥289.47 Million | ▼ -188.9% |
| 2016 | 0.53x | CN¥44.40 Million | CN¥84.53 Million | CN¥40.13 Million | ▲ +1.6% |
| 2015 | 0.52x | CN¥36.49 Million | CN¥70.61 Million | CN¥34.12 Million | ▲ +131.7% |
| 2014 | -1.63x | CN¥-31.42 Million | CN¥19.26 Million | CN¥50.69 Million | ▼ -186.2% |
| 2013 | -0.57x | CN¥-36.28 Million | CN¥63.65 Million | CN¥99.93 Million | ▲ +18.4% |
| 2012 | -0.70x | CN¥-49.43 Million | CN¥70.75 Million | CN¥120.18 Million | ▲ +59.3% |
| 2011 | -1.72x | CN¥-156.80 Million | CN¥91.23 Million | CN¥248.03 Million | ▼ -25.3% |
| 2010 | -1.37x | CN¥-60.45 Million | CN¥44.06 Million | CN¥104.52 Million | ▼ -423.5% |
| 2009 | -0.26x | CN¥-9.55 Million | CN¥36.43 Million | CN¥45.98 Million | ▼ -148.1% |
| 2008 | 0.54x | CN¥86.28 Million | CN¥158.47 Million | CN¥72.19 Million | ▲ +10707.9% |
| 2007 | 0.01x | CN¥307.69K | CN¥61.08 Million | CN¥60.77 Million | ▼ -98.8% |
| 2006 | 0.43x | CN¥13.44 Million | CN¥31.11 Million | CN¥17.68 Million | — |